What is Hismanal used for?

Hismanal is indicated for Allergic conjunctivitis, Allergic rhinitis, Chronic idiopathic urticaria, Sneezing.

What development phase is Hismanal in?

Hismanal is FDA-approved (marketed).

What is the generic name of Hismanal?

ASTEMIZOLE is the generic (nonproprietary) name of Hismanal.

Last reviewed 2026-04-20 · How we verify

Hismanal (ASTEMIZOLE)

FDA-approved withdrawn Small molecule Quality 33/100

At a glance

Generic name	ASTEMIZOLE
Drug class	High Risk QT Prolonging Agents
Target	Potassium voltage-gated channel subfamily H member 2
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved
First approval	1988

Approved indications

Allergic conjunctivitis
Allergic rhinitis
Chronic idiopathic urticaria
Sneezing

Common side effects

No common side effects on file.

Drug interactions

High Risk QT Prolonging Agents
azithromycin
cisapride
clarithromycin
crizotinib
darunavir
efavirenz
erythromycin
fluvoxamine
indinavir
itraconazole
ketoconazole

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Hismanal CI brief — competitive landscape report
Hismanal updates RSS · CI watch RSS